Join
Live feed
·
PRReleasevia Quantisnow
Bristol-Myers Squibb Company logo
Evotec SE logo

Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMY (Bristol-Myers Squibb Company), EVO (Evotec SE) and more on Quantisnow.